| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10596125 | Bioorganic & Medicinal Chemistry Letters | 2013 | 6 Pages |
Abstract
The design of a novel, peripherally restricted, selective T-type calcium channel (Cav3.2) inhibitors by systematic chemical modifications is described.
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
![Discovery of N-[[1-[2-(tert-butylcarbamoylamino)ethyl]-4-(hydroxymethyl)-4-piperidyl]methyl]-3,5-dichloro-benzamide as a selective T-type calcium channel (Cav3.2) inhibitor](/preview/png/10596125.png "First Page Preview: Discovery of N-[[1-[2-(tert-butylcarbamoylamino)ethyl]-4-(hydroxymethyl)-4-piperidyl]methyl]-3,5-dichloro-benzamide as a selective T-type calcium channel (Cav3.2) inhibitor")
Authors
Fabrizio Giordanetto, Andreas WÃ¥llberg, Laurent Knerr, Nidhal Selmi, Victoria Ullah, Fredrik Thorstensson, Ã
sa Lindelöf, Staffan Karlsson, Grigorios Nikitidis, Antonio Llinas, Qing-Dong Wang, Anders Lindqvist, Ã
got Högberg, Emma Lindhardt,